ARCHIVES

FDA Declares Taxol Orphan Drug For KS; Can IVAX Break Bristol’s Exclusivity?

This article is from The Cancer Letter archive.

Vol. 23 No. 32 | August 15, 1997

Download PDF Visit The Full Archive

Related Articles

NCI Cooperative Group, Cancer Center Trials Listed

August 31, 2007

Oncology Practice Group Leaves Allegheny For Former Rival UPCI; Will NSABP Follow?

June 30, 2000

FDA Clears Rapid Test For Aspergillus Infection

May 30, 2003

Hutchinson Center Receives NCI Grant For Immunotherapy Network

October 15, 2010

Brothers Of Prostate Cancer Patients At Risk Of Diagnosis

August 27, 2010

NIH reiterates Position On Closed Meeting Of BSC Chairmen

September 23, 1994